Clinical Research Directory
Browse clinical research sites, groups, and studies.
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
Sponsor: University of Delaware
Summary
The purpose of this study is to identify the impact of estradiol (E2) on the associations between (a) responsivity to daily stress or (b) sleep variability with vascular function in midlife premenopausal women.
Key Details
Gender
FEMALE
Age Range
40 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-11-15
Completion Date
2027-10
Last Updated
2024-12-20
Healthy Volunteers
Yes
Conditions
Interventions
ganirelix acetate
Ganirelix acetate (Antagon) will be used to prevent endogenous production of ovarian hormones in young women. Ganirelix is derived from native GnRH, and acts by competitively blocking GnRH receptors on the pituitary and subsequent pathways. Thus, administration of the GnRH antagonist (GnRHant) suppresses steroidogenesis, leading to low or undetectable serum estrogen and progesterone concentrations, which occurs within two days of initiation of administration. Women will self-administer subcutaneous injections (0.25 mg/day in 0.5 ml of normal saline) of the GnRH antagonist ganirelix acetate (Antagon, Organon, Inc., West Orange, New Jersey,) every day for \~12-15 days (starting on day \~2-4 of the menstrual cycle). Testing will occur on day 3-4 and day14-15 of using Antagon.
Locations (1)
University of Delaware
Newark, Delaware, United States